Catalent

GLP-1 and Keytruda gained momentum in Q3

The reporting season is in full swing and large parts of Big Pharma have now released their reports for the third...

News roundup Wednesday June 29

The latest from BioStock

Xintela's collaboration with the orthopedics giant may be expanded

Cell therapy and oncology company Xintela is in a...

Eventful 2019 awaits for Xintela

Positive preclinical results from Xintela's stem cell study were recently presented...

Xintela: »Interest in cell therapy is very high in Asia«

With a busy 2018 in the rearview mirror, Xintela has...